| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3d509f39620e4265a870f5b02f5db96 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2002-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63930ff092d6ccdf0bad355dbfc56d2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03aaadac7070f9d811ceacdc4aa55523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_494599d57c6671f881547c3d8c9804e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec49b2eeeb8689003d9ec1aa729735eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6426f5b83adbb628789a07a5929cbf49 |
| publicationDate |
2002-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2440474-A1 |
| titleOfInvention |
Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment |
| abstract |
The present invention provides of using multimeric MHC class II/peptide complexes. In one aspect, methods provided for identifying MHC class II- restricted immune epitopes of a predetermined polypeptide antigen. Methods f or identifying an immunostimulatory epitope for a predetermined polypeptide antigen are provided. In a related aspect, methods for screening a therapeut ic polypeptide agent for an MHC class II epitope are provided. In other aspects , methods for modulating T cells and for determining or monitoring an MHC clas s II-restricted immune status of a patient are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103235136-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103235136-B |
| priorityDate |
2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |